N-acetylcysteine prevents preterm birth by attenuating the LPS-induced expression of contractile associated proteins in an animal model

J Matern Fetal Neonatal Med. 2012 Nov;25(11):2395-400. doi: 10.3109/14767058.2012.697942. Epub 2012 Jun 25.

Abstract

Objective: Intrauterine infection is associated with maternal immune activation (MIA) leading to preterm birth through upregulation of contractile associated proteins (CAPs). We hypothesized that N-acetylcysteine would decrease NF-κB activation and CAP expression in a MIA model for preterm birth.

Methods: Pregnant CD-1 mice were given intrauterine LPS or saline on day 15/20. They received NAC or saline prior to injection and were monitored until delivery. The rate of preterm birth in the control, LPS, and LPS + NAC animals was determined. In another group, animals were sacrificed 6 h after treatment and myometrium was collected. COX-2, connexin 43, and oxytocin receptor expression was determined.

Results: LPS administration resulted in preterm birth and this effect was attenuated by NAC. LPS increased COX-2, connexin 43, and oxytocin receptor expression. NAC significantly decreased COX-2 expression. LPS increased NF-κB activation; this was attenuated by NAC.

Conclusion: NAC may be beneficial in prevention of MIA-related preterm birth through attenuation of NF-κB activation and COX-2 upregulation.

Publication types

  • Evaluation Study

MeSH terms

  • Acetylcysteine / pharmacology*
  • Acetylcysteine / therapeutic use
  • Animals
  • Connexin 43 / genetics
  • Connexin 43 / metabolism
  • Contractile Proteins / genetics*
  • Contractile Proteins / metabolism
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Lipopolysaccharides / pharmacology*
  • Mice
  • Models, Animal
  • Models, Biological
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Pregnancy
  • Premature Birth / genetics
  • Premature Birth / metabolism
  • Premature Birth / pathology
  • Premature Birth / prevention & control*
  • Receptors, Oxytocin / genetics
  • Receptors, Oxytocin / metabolism
  • Uterine Contraction / drug effects
  • Uterine Contraction / genetics
  • Uterine Contraction / immunology
  • Uterine Contraction / metabolism
  • Uterus / drug effects
  • Uterus / immunology
  • Uterus / metabolism

Substances

  • Connexin 43
  • Contractile Proteins
  • GJA1 protein, mouse
  • Lipopolysaccharides
  • NF-kappa B
  • OXTR protein, mouse
  • Receptors, Oxytocin
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Acetylcysteine